The Federal Ministry for Education and Research (BMBF) has selected three public-private consortia to receive €100 million ($142.9 million) to advance the efficiency of pharmaceutical research. The Max Planck Drug Discovery & Development Center will commercialize research from the Max Planck Institutes and other research institutes. The Neuroallianz consortium consists of 12 partners, including Schwarz […]
Due to the upcoming presidential elections, the US Congress essentially has put the fiscal year 2009 budget, which started October 1, 2008, on hold. A continuing resolution was passed to fund the federal agencies that did not receive final budget appropriations through March 6, 2009. Among the agencies operating under the continuing resolution are three […]
China is the best outsourcing destination for pharmaceutical R&D and manufacturing in Asia, according to an analysis by PricewaterhouseCoopers (PwC). The results are based on an analysis of cost, risk and market opportunity, which were assigned the respective weights of 33%, 37% and 30%. The other top 5 destinations are India, Korea, Taiwan and Japan. […]
The addition of the chemical melamine to Chinese dairy products has caused more than 10 infant deaths worldwide and over 50,000 children in China to be hospitalized. Melamine in itself is not harmful, but when levels are high enough, it can cause crystals to form in the liver, leading to renal failure. This scandal comes […]
Carlsbad, CA 10/9/08; 10/15/08—Invitrogen announced it has amended the terms of its merger agreement with Applied Biosystems (ABI). To allow the companies’ stockholders to consider the amendment, the meetings to vote on the merger will take place October 28, instead of October 16. The amendment eliminates the requirement that the parties receive certain opinions regarding […]
Company Announcements During fiscal year 2008, Applied Biosystems discontinued the manufacture of the 433A Peptide Synthesis and the Procise Protein Sequencing systems, but will continue to provide support for existing systems for five years. Oxford Nanopore Technologies announced in August an exclusive agreement to develop and commercialize nanopore technologies developed at Harvard University, the University […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 12.8% to $912.0 million, and operating profits jumped 18.7% to $273.5 million. Adjusted operating margins improved 150 basis points to 30.0% of sales. Biohit Oy’s second-quarter sales grew 14% to €9.1 million ($14.2 million = €0.64 = $1) from €7.9 million ($10.7 million = €0.74 = […]
Santa Clara, CA 10/13/08—Affymetrix has announced that it expects third-quarter revenues to be approximately $75 million, compared to $95.0 million last year. Analysts had forecasted revenues of $90.1 million, according to Thomson Financial. The company does not provide revenue guidance on a quarterly basis. Affymetrix attributed the shortfall to greater competition for research funding and […]
Venlo, the Netherlands 10/1/08; Uppsala, Sweden 10/1/08—QIAGEN NV has acquired the assets of the Biosystems business and the remaining 17.5% of Corbett Life Science (see IBO 7/15/08) from Biotage AB for approximately $53 million in cash and performance milestone payments of up to $7 million over four years. The Biosystems business develops and sells the […]
A total of 633 biotechnology medicines for more than 100 diseases are currently in development, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). By therapeutic category, with some medicines counted in more than one category, the number of biotech medicines in development for cancer and related conditions, at 254, and infectious disease, at […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
